Psychotherapy initiation is associated with discontinuation of psychotropic medications without dose escalation: a ten-year real-world cohort study (2014-2024) - Summary - MDSpire

Psychotherapy initiation is associated with discontinuation of psychotropic medications without dose escalation: a ten-year real-world cohort study (2014-2024)

  • By

  • Teresa Dolores Pomares Carreres

  • Guillermo Martínez Conesa

  • Francisco Navarrete

  • June 22, 2026

  • 0 min

Share

Objective:

To evaluate whether initiation of psychotherapy is associated with short-term changes in psychotropic medication exposure and regimen complexity, and to examine differences by sex, age, and diagnostic category.

Approach:
    Key Findings:
    • Thecohortcomprised86,502patientsand20.76milliondispensations.Themediannumberofpsychotropicmedicationsdecreasedfrom5to2(p<0.001).Totaldoseremainedstable(medianDefinedDailyDose≈21.7;p=0.999).Benzodiazepineusedeclinedfrom87.6%to67.5%andantidepressantusefrom81.8%to68.8%(bothp<0.001).Menweremorelikelythanwomentodiscontinuebenzodiazepines(oddsratio1.27,95%CI1.13–1.43).Simplificationincreasedwithage,withthelargestbenzodiazepinereductionsoccurringindepressive,personality,andepisodicmooddisorders.
    Interpretation:

    In routine public mental health care, psychotherapy initiation is associated with substantial simplification of psychotropic treatment regimens without increasing overall medication dose.

    Conclusion:

    The study supports a potential role of psychotherapy in facilitating rational medication simplification.

Original Source(s)

Related Content